- New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer
- Does My Child Have a Language Disorder?
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- ASCs’ vendor problem
- Providence’s physician chief on its ‘holistic’ approach to value-based care
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Anesthesia job market faces ‘major disruption’
- Florida system raises $100M for new ED
- North Carolina system names COO
- Mark Cuban wants to bring drug manufacturing to hospitals’ doorsteps — literally
- UCI Health names chief AI officer
- Nevada hospital names CEO
- Saint Luke’s taps president for 2 hospitals
- Dental community mourns dentist killed in murder-suicide
- Mass General Brigham, CVS deal could raise healthcare spending $40M annually: Report
- Ideal Dental opens 1st Oklahoma practice, expands in 2 more states
- PDS Health eyes the next era of medical-dental integration
- Mark Cuban dives into direct contracting
- HCA executive pay by the numbers
- Iris Telehealth offers behavioral health analytics platform
- HHS names chief economist, regulatory leader to address healthcare affordability
- Loma Linda University Health names new president
- The best ASCs for colonoscopy, endoscopy in the South: US News
- Tennessee moves forward with CON repeal
- Dental schools take action to alleviate workforce shortages: 6 updates
- American Medical Group Association partners with Talkiatry to expand psych access
- Trump nominates CDC director
- ChristianaCare, Cardiovascular Physicians of Delaware to open joint venture ASC
- 5 states regulating AI in mental health
- Centerstone debuts $13M youth behavioral health campus in Missouri
- 3 DSOs making headlines
- Maine restricts noncompetes for rural healthcare workers
- Heartland Dental opens Florida office
- The 10 biggest ASC deals of the last 5 years
- Affordability, transparency: A look at large employers' top healthcare concerns
- 10 dental Medicaid updates to know from Q1
- White House eyes ibogaine research expansion
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The future of medical-dental integration is here
- Texas dentist has license suspended
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- What’s the deal with insurer mental health parity violations?
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- EPA Delays Decisions on 'Forever Chemicals'
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- Progyny unveils new fertility benefit option for small, mid-size employers
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
Beyond RFK, Jr., there are a number of individuals in the running to take various health care posts in the upcoming Trump Administration:
https://rollcall.com/2024/11/07/a-look-at-those-who-could-be-on-trumps-health-team-short-list/
A look at those who could be on Trump’s health team short list
RFK Jr., Jindal among those thought to be contenders for key Trump health positions
By Ariel Cohen - November 7, 2024President-elect Donald Trump has pledged to involve anti-vaccine activist and conspiracy theorist Robert F. Kennedy Jr. in his next administration in some capacity, but whoever else he picks to run the major health agencies will have a major impact on the GOP health agenda of the next four years.
Top posts require Senate confirmation, meaning Trump will need Senate buy-in too. Positions include Health and Human Services secretary, which requires Senate confirmation; Centers for Disease Control and Prevention director, which will require Senate confirmation beginning in January 2025; Food and Drug Administration commissioner and National Institutes of Health director, which also require Senate confirmation.
Republican health priorities will likely include increased health care transparency and lowering drug costs, as well as limiting health care access for LGBTQ individuals and, potentially, further limiting access to abortion. This might look like rolling back Title X regulations, which are federal dollars for family planning, or the Mexico City policy, which blocks federal funding for nongovernmental organizations that provide abortion counseling or services.
It could also look like rollbacks of rules regarding nondiscrimination in health care, drug price negotiation interference or nursing home staffing mandates.
Here are some of the names being mentioned for future Trump health policy roles:
Robert F. Kennedy Jr.
Trump reiterated his pledge to involve RFK Jr. in his administration during his victory speech on Tuesday, but it’s unlikely he’ll be nominated to lead a major agency.“He’s going to help make America healthy again. He’s a great guy and he really means it. He wants to do some things, and we’re going to let him go to it,” Trump told supporters at the West Palm Beach Convention Center during his victory speech Tuesday night.
In an MSNBC interview on Wednesday morning, Kennedy said he would clear out entire departments of the FDA, including the nutrition department, which was recently revamped as part of the agency’s effort to create a Human Foods Program.
Many experts say they imagine Kennedy will serve more as an informal adviser to Trump, because it could be difficult to get a majority of senators, even in a GOP-led chamber, to confirm him.
“I see someone like that a little more in kind of the Elon Musk type of role … somebody who is whispering in the ear of the administration,” said K&L Gates government affairs adviser and former RNC delegate Amy Carnevale.
Joseph A. Ladapo
Florida Surgeon General Joseph Ladapo is under consideration to lead HHS, ABC News first reported.Like Kennedy, Ladapo is a vaccine skeptic.
Under his leadership, Florida skirted CDC pandemic guidelines regarding masks and social distancing, as well as vaccine requirements for children. In October 2022, he recommended that men between ages 18 and 39 avoid the COVID-19 mRNA vaccines because of a slightly increased risk for cardiac-related deaths. The study he referenced was widely criticized, and the FDA and CDC sent him a letter asking him to stop spreading disinformation.
Lapado was first appointed by Republican Gov. Ron DeSantis in 2021.
After Trump’s win, Ladapo tweeted on Wednesday that the “future of health freedom in America looked brighter.”
“Just as in Florida, it’s time to say ‘No’ to trampling on people’s rights, to gaslighting citizens about experimental vaccines that harm instead of help & to muzzling doctors who dissent with orthodoxy. Light triumphs over darkness,” he said.
Roger Severino
Roger Severino, the former director of the HHS Office of Civil Rights under Trump and current vice president of domestic policy at the Heritage Foundation, wrote the HHS portion of Project 2025.Severino is one of the most vocal abortion opponents in the GOP. He has repeatedly said that the government should not treat abortion as health care and calls for reversing approval of medication abortion, codifying the Hyde amendment and removing the morning-after pill from the contraceptive mandate.
In Project 2025 he also encourages the NIH to stop promoting “junk gender science” and redefine the definition of sex so it does not include gender identity, among other things.
Brian Blase
Brian Blase, a former Trump special assistant to the president for economic policy at the White House’s National Economic Council and currently the president of Paragon Health Institute, could come back around for a second administration.In his most recent email blast, Blase called Trump’s victory “an opportunity to build on the health care successes of his first term” — pointing mainly to policies that expanded the availability of short-term health plans, association health plans and price transparency.
During the Biden administration, Blase has been analyzing and promoting the expansion of health savings account plans. He has proposed providing lower-income exchange enrollees the option to receive a portion of their subsidy as a HSA deposit rather than a subsidy to the insurer.
He also argued against the Biden administration’s expansion of Medicaid during the COVID-19 public health emergency, and called for limiting the program’s scope to just the lowest-income and most vulnerable individuals.
Paul Mango
Mango, another former Trump administration official and an adviser at the Paragon Institute, served as HHS deputy chief of staff from 2019 through 2021 and served as HHS Secretary Alex Azar’s formal liaison to Operation Warp Speed. From 2018 to 2019, Mango served as chief of staff for the Centers for Medicare and Medicaid Services. His institutional knowledge of the department could be seen as an asset to an incoming Trump administration.Eric Hargan
Another Trump administration alumni, Eric Hargan served as deputy HHS secretary under Trump and also as acting secretary. He also served on the board of Operation Warp Speed. Hargan oversaw the setup and launch of the pandemic-era Provider Relief Fund.Hargan was also acting HHS deputy secretary under then-President George W. Bush.
These days he’s the founder and CEO of the Hargan Group, where he focuses on health care, government relations and public affairs.
Joe Grogan [not the podcaster!]
Joe Grogan served as an assistant to Trump and director of his Domestic Policy Council. He also was a member of the White House Coronavirus Task Force in the early days of the pandemic. But Grogan didn’t stay in the administration the entirety of the first term and resigned in May 2020 to join Verde Technologies.During his time in the White House, Grogan worked closely on efforts to lower drug costs, ban surprise medical bills and expand COVID-19 testing. He’s been a vocal opponent of the Biden administration’s policies to have Medicare negotiate drug costs, saying it would lead to less pharmaceutical innovation, and has repeatedly called for FDA reform to speed up the drug review and approval process.
These days Grogan is also at Paragon Health Institute where he serves as chairman of the board.
Bobby Jindal
The former Louisiana governor is now chair of the Center for a Healthy America, a wing of the America First Policy Institute, a conservative think tank advising Trump. Jindal’s focus on health policy isn’t new: he served as HHS assistant secretary under George W. Bush. Over the last few years he’s called for changes to the health care exchanges, increased price transparency measures and advocated against single-payer health care.
Robert F. Kennedy, Jr. is not the only Trump nominee catching flack. The smart, prescient Dr. Jay Bhattacharya is also catching slings and arrows from envious nonentities:
Pandemic Hawks Circle Dr. Jay: Pundits Launch Attacks on Bhattacharya Ahead of his Confirmation HearingsBy Jonathan Turley - December 29, 2024
For those who opposed the censorship and cancel campaigns during the pandemic, Dr. Jay Bhattacharya became an iconic figure of resistance. Unfortunately, the same can be said of the anti-free speech movement and pandemic hawks. Bhattacharya, who co-authored the Great Barrington Declaration and was a vocal critic of COVID-19 policies, has been nominated as the next head of the National Institutes of Health. As I wrote this weekend in my column, the nomination was heralded by many as a turning point for the NIH. It is also a rallying cry for those who supported the earlier measures, as shown by a hit piece in Scientific American, accusing him of being a danger to the very lives of American citizens.
Bhattacharya was censored, blacklisted, and vilified for the last four years due to his opposing views on health policy, including opposing wholesale shutdowns of schools and businesses. He was recently honored with the prestigious “Intellectual Freedom” award from the American Academy of Sciences and Letters.
Before the pandemic, Bhattacharya was one of the most respected scientists in the world and served as the director of Stanford’s Center for Demography and Economics of Health and Aging.
That all changed when he dared to question the science behind pandemic policies, including suggesting that natural immunity would be as good if not better protection for young healthy individuals.
It did not matter that positions once denounced as “conspiracy theories” have been recognized or embraced by many.
Some argued that there was no need to shut down schools, which has led to a crisis in mental illness among the young and the loss of critical years of education. Other nations heeded such advice with more limited shutdowns (including keeping schools open) and did not experience our losses.
Others argued that the virus’s origin was likely the Chinese research lab in Wuhan. That position was denounced by the Washington Post as a “debunked” coronavirus “conspiracy theory.” The New York Times Science and Health reporter Apoorva Mandavilli called any mention of the lab theory “racist.”
Federal agencies now support the lab theory as the most likely based on the scientific evidence.
Likewise, many questioned the efficacy of those blue surgical masks and supported natural immunity to the virus — both positions were later recognized by the government.
Others questioned the six-foot rule, which shut down many businesses, as unsupported by science. In congressional testimony, Dr. Anthony Fauci recently admitted that the rule “sort of just appeared” and “wasn’t based on data.” Yet not only did it result in heavily enforced rules (and meltdowns) in public areas, but the media further ostracized dissenting critics.
Again, Fauci and other scientists did little to stand up for these scientists or call for free speech to be protected. As I discuss in my new book, “The Indispensable Right,” the result is that we never really had a national debate on many of these issues and the result of massive social and economic costs.
Now, those who supported these policies are gathering to oppose Bhattacharya.
It is hardly surprising that one of the first hit pieces came from Scientific American. The magazine not only helped lead the mob response to the pandemic but has also been criticized for abandoning neutrality in recent elections.
Only a few weeks ago, editor-in-chief Laura Helmuth posted a raving, profanity-laden meltdown on social media in which she effectively called over 77.3 million Americans who voted for President-elect Donald Trump both “fascists” and bigots.
Now the magazine has published an article by Dr. Steven Albert, a professor and the Hallen Chair of Community Health and Social Justice at the University of Pittsburgh’s School of Public Health.
Two specific attacks stand out in the piece.
The “Personal Pique” of Censorship
First, Dr. Albert suggests that Dr. Bhattacharya was never actually censored. He insists that what Bhattacharya calls censorship was merely the fact that “social media venues … dropped his messaging.” It is curious wording and it is not quite clear what Dr. Albert is trying to say.
When Albert’s article appeared, various other outlets advanced the same claim. For example, MSNBC (which also was a leading outlet in the attacks on skeptics and dissenters during the pandemic) mocked the claim that Bhattacharya was censored.
“The problem is there’s basically zero evidence to support Bhattacharya and his supporters’ claims of censorship. It is true that some internet sites appeared to remove or limit access to the document. But, as with medical professionals not being sure how best to handle Covid, the same was true of social media companies, which struggled with how best to handle the spread of potentially dangerous information that could have resulted in harm to users.
Many companies chose, of their own free will and as they were allowed as private actors, to downplay certain information that they felt might do more harm than good. That is their own First Amendment-protected right as private entities in the United States.”
The article goes on to suggest that there is no proof of censorship without government direction or control.
As the ACLU has long maintained, censorship occurs in both private and governmental forums. The same figures insist that, if there is no violation of the First Amendment (which only applies to the government), there is no free speech violation. The First Amendment was never the exclusive definition of free speech. Free speech is viewed by many of us as a human right; the First Amendment only deals with one source for limiting it. Free speech can be undermined by private corporations as well as government agencies.
There is also ample evidence of government officials pushing social media companies to censor pandemic critics. MSNBC simply excuses the censorship by saying that these companies “struggled with how best to handle the spread of potentially dangerous information that could have resulted in harm to users.” In reality, the censorship itself cost the nation greatly. We never had the type of debate that we need on the efficacy of natural immunities, masks, or other precautions. We never explored the science supporting the six-foot rule. We suffered immense costs in education and the economy rather than allowing scientists on both sides to be heard equally on such forums.
Instead, Bhattacharya became a persona non grata in academia and was subjected to cancel campaigns. In the Los Angeles Times, columnist Michael Hiltzik decried how “we’re living in an upside-down world” because Stanford allowed these scientists to speak at a scientific forum. He was outraged that, while “Bhattacharya’s name doesn’t appear in the event announcement,” he was an event organizer. Hiltzik also wrote a column titled “The COVID lab leak claim isn’t just an attack on science, but a threat to public health.”
Critics of Bhattacharya have also cited the fact that he retained his position, unlike some who were dropped by their institutions or associations. Survival is hardly the test of whether someone was censored or canceled. Bhattacharya holds a position with academic protections, as do some of us fortunate to have tenure in this age of rage. The fact that he persisted and the American people rejected the establishment in this election is not proof that he was not targeted or blocked from academic settings or social media sites.
Dr. Albert dismisses the censorship debate as a “personal pique” and “a distraction” that “should not obscure the central focus of U.S. public health policy during the pandemic.” Obviously, for many of us who value free speech and a diversity of viewpoints, it is a bit more than a “personal pique.”
The “Vanity” of Personal Autonomy
The second point that stood out in the Scientific American article was the warning that Bhattacharya is too focused on individual rights and personal autonomy to be the head of NIH. Dr. Albert declares:
“Pitting personal autonomy against the application of science to policy is fine for vanity webcasts and think tanks, but inappropriate for NIH leadership. If he would rather focus on promoting personal autonomy in pandemic policy, perhaps he is being nominated to the wrong agency.”
It is a chilling observation from a leading public health figure. NIH leadership suggests policies impacting a nation and must balance the costs and benefits of any given course. The NIH states that it is focused not just on “scientific integrity” but “public accountability and social responsibility in the conduct of science.” Isn’t individual rights part of that responsibility?
I would hope that the head of NIH (indeed every NIH official) would place individual rights and personal autonomy as one of the most prominent considerations in setting policies.policy-making Indeed, the NIH routinely discusses and publishes papers on the importance of personal autonomy when discussing subjects like abortion.
These two points are linked on some level. The nation was divided on many COVID policies, and doubts only grew with the censorship and intolerance that was evident during the pandemic. The NIH contributed to that mistrust with its heavy-handed tactics and viewpoint intolerance. One of the victims of that period will now head the NIH. That experience could be invaluable as Dr. Bhattacharya steers his agency toward a more transparent and tolerant path.
Jonathan Turley is the Shapiro professor of public interest law at George Washington University.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














